[1]
S. Başcı, “Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents”, Med.Lab.Tech.J., vol. 6, no. 2, pp. 92–99, Nov. 2020.